The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 22, 2020

Filed:

Mar. 14, 2019
Applicant:

Enlitic, Inc., San Francisco, CA (US);

Inventors:

Kevin Lyman, Fords, NJ (US);

Keith Lui, San Francisco, CA (US);

Anthony Upton, Malvern, AU;

Li Yao, San Francisco, CA (US);

Ben Covington, San Francisco, CA (US);

Assignee:

Enlitic, Inc., San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G06K 9/00 (2006.01); G16H 10/60 (2018.01); H04L 29/06 (2006.01); G16H 30/40 (2018.01); G16H 15/00 (2018.01); G06K 9/62 (2006.01); G06T 5/00 (2006.01); G06T 5/50 (2006.01); G06T 7/00 (2017.01); G06T 11/00 (2006.01); G06N 5/04 (2006.01); G16H 30/20 (2018.01); G06N 20/00 (2019.01); G06F 9/54 (2006.01); G06T 7/187 (2017.01); G06T 7/11 (2017.01); G06F 3/0482 (2013.01); G06T 3/40 (2006.01); A61B 5/00 (2006.01); G16H 50/20 (2018.01); G06F 21/62 (2013.01); G06Q 20/14 (2012.01); G16H 40/20 (2018.01); G06F 3/0484 (2013.01); G06Q 10/06 (2012.01); G16H 10/20 (2018.01); G06T 7/10 (2017.01); G06T 11/20 (2006.01); G06F 16/245 (2019.01); G06T 7/44 (2017.01); G06N 20/20 (2019.01); G06K 9/20 (2006.01); H04L 29/08 (2006.01); G16H 50/70 (2018.01); G06T 7/70 (2017.01); G16H 50/30 (2018.01); A61B 5/055 (2006.01); A61B 6/03 (2006.01); A61B 8/00 (2006.01); G06K 9/66 (2006.01); A61B 6/00 (2006.01); G06Q 50/22 (2018.01); G06F 40/295 (2020.01);
U.S. Cl.
CPC ...
G16H 10/60 (2018.01); A61B 5/7264 (2013.01); G06F 3/0482 (2013.01); G06F 3/0484 (2013.01); G06F 9/542 (2013.01); G06F 16/245 (2019.01); G06F 21/6254 (2013.01); G06K 9/2063 (2013.01); G06K 9/6231 (2013.01); G06K 9/6254 (2013.01); G06K 9/6256 (2013.01); G06K 9/6262 (2013.01); G06K 9/6277 (2013.01); G06N 5/04 (2013.01); G06N 5/045 (2013.01); G06N 20/00 (2019.01); G06N 20/20 (2019.01); G06Q 10/06315 (2013.01); G06Q 20/14 (2013.01); G06T 3/40 (2013.01); G06T 5/002 (2013.01); G06T 5/008 (2013.01); G06T 5/50 (2013.01); G06T 7/0012 (2013.01); G06T 7/0014 (2013.01); G06T 7/10 (2017.01); G06T 7/11 (2017.01); G06T 7/187 (2017.01); G06T 7/44 (2017.01); G06T 7/97 (2017.01); G06T 11/001 (2013.01); G06T 11/006 (2013.01); G06T 11/206 (2013.01); G16H 10/20 (2018.01); G16H 15/00 (2018.01); G16H 30/20 (2018.01); G16H 30/40 (2018.01); G16H 40/20 (2018.01); G16H 50/20 (2018.01); H04L 67/12 (2013.01); H04L 67/42 (2013.01); A61B 5/055 (2013.01); A61B 6/032 (2013.01); A61B 6/5217 (2013.01); A61B 8/4416 (2013.01); G06F 40/295 (2020.01); G06K 9/6229 (2013.01); G06K 9/6267 (2013.01); G06K 9/66 (2013.01); G06K 2209/05 (2013.01); G06Q 50/22 (2013.01); G06T 7/70 (2017.01); G06T 2200/24 (2013.01); G06T 2207/10048 (2013.01); G06T 2207/10081 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/10116 (2013.01); G06T 2207/10132 (2013.01); G06T 2207/20076 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/20084 (2013.01); G06T 2207/30004 (2013.01); G06T 2207/30008 (2013.01); G06T 2207/30016 (2013.01); G06T 2207/30061 (2013.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01);
Abstract

A clinical trial re-evaluation system is operable to perform at least one assessment function on a set of medical scans for each of a first subset of a set of patients of a failed clinical trial to generate automated assessment data for each of the first subset of the set of patients. The first subset of the set of patients corresponds to a subset of human assessment data determined to have failed to meet criteria of the clinical trial. Patient re-evaluation data is generated for each of the first subset of the set of patients by comparing the automated assessment data to the criteria. The patient re-evaluation data for a second subset of the first subset of the set of patients indicates the automated assessment data passes the criteria. Trial re-evaluation data is generated based on the patient re-evaluation data for transmission to a computing device for display.


Find Patent Forward Citations

Loading…